Le Lézard
Classified in: Health
Subject: SVY

Global Molecular Imaging Market to Reach $11.13 Billion by 2028


NEW YORK, Aug. 20, 2019 /PRNewswire/ --

Global Molecular Imaging Market Value and Estimation


Read the full report: https://www.reportlinker.com/p05807624/?utm_source=PRN 



As per the report, the global molecular imaging market analysis conducted by BIS Research, the market was valued at approximately $6.84 billion in 2018 and is anticipated to reach $11.13 billion by 2028. Presently, the incidence of chronic disorders such as cardiovascular, oncological, and neurological disorders is rising at alarming rates and is creating an increased economic burden on the healthcare providers and the patients.

To combat the growing incidence and to reduce the costs associated with disease management healthcare providers as well as the researchers are promoting and identifying novel methods for preventive care and early detection. Molecular imaging is one such highly advanced method in the field of medical imaging which allows the functional diagnosis and aids in the characterization of the physiological events at the cellular and molecular level.

Expert Quote on Global Molecular Imaging Market

"North America is currently the leading contributor to the molecular imaging market. The market was valued $3.89 billion in 2018. Factors such as rising demand for minimally invasive surgeries, increasing cases of chronic diseases, approval of novel radiotracers, and the growing awareness regarding molecular imaging are driving the growth of the North American molecular imaging market. However, the Asia-Pacific is expected to register the highest CAGR of 6.68% during the forecast period 2019-2028".

Scope of the Market Intelligence on Global Molecular Imaging Market

The purpose of the study is to gain a holistic view of the molecular imaging market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products allied with the molecular imaging market, which include imaging systems, imaging agents, and imaging software.

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

Market Segmentation

The global molecular imaging market is segmented into four different parts: by product, by application, by end user, and by region.The global market value was estimated using these three different approaches and was validated with one another.

These segments are further segmented into several sub-segments to ease the market estimation.

With the increasing incidence of chronic disorders, increased digital platform penetration, and the increased utilization of molecular imaging in disciplines such as precision medicine the molecular imaging market is expected to witness a gradual growth. Moreover, the ongoing technological advancements have led to the identification of multimodality molecular imaging technology as an innovative approach for the functional as well as anatomical diagnosis.

The use of multimodality imaging techniques including PET-MRI, PET-CT, and SPECT-CT is becoming increasingly prevalent attributed to which the multimodality imaging technology is expected to dominate the market. Moreover, with the advent of novel imaging agents including the multimodality reporter genes is expected to expand the clinical application of techniques such as optical imaging and targeted molecular ultrasound because of which these segments are expected to witness an impressive CAGR during the forecast period.

The global molecular imaging market is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.North America is the leading contributor to the global molecular imaging market followed by Europe.

However, the Asia-Pacific region is expected to register a highest CAGR during the forecast period.

The global molecular imaging market is dominated by the U.S. and the European players. The U.S.-based companies, Cardinal Health and General Electric Company and the European companies Siemens Healthcare GmbH and Koninklijke Philips N.V. GmbH accounted for more than 70% of the market value in 2018.

Key Players in the Market

The key players who have significant contributions to the global molecular imaging equipment market are Advanced Accelerator Applications, Bruker Corporation, Canon Inc., Digirad Corporation, ESAOTE SPA, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V. GmbH, PerkinElmer Inc., Positron Corporation, Siemens Healthcare GmbH, SurgicEye GmbH, and Thermo Fisher Scientific, among others.

Key Questions Answered in this Report:
? What is the total market size at present and forecast for global molecular imaging market by 2028?
? What are the current key trends witnessed by the global molecular imaging market?
? What are the key market dynamics i.e. drivers, restraints, and opportunities for molecular imaging market?
? How would artificial intelligence-enabled image analytics result in a dynamic shift in the growth of molecular imaging market during the forecast period?
? What are the key strategies incorporated by the leading players of molecular imaging market?
? What is the market share of key competitors for the product categories?
? What are the regulations influencing molecular imaging market, across regions?
? What is the current total market size and the forecast for different product categories available in molecular imaging market by 2028?
? How would imaging agents evolve to be dominating contributors in the global molecular imaging market revenue and why?
? What is the current total market estimation and forecasts of molecular imaging products across different countries by 2028?

Countries Covered
? North America
? U.S.
? Canada
? Europe
? Germany
? U.K.
? France
? Italy
? Spain
? Netherlands
? Switzerland
? Rest-of-Europe
? Asia-Pacific
? China
? Japan
? India
? Australia
? South Korea
? Rest-of-Asia-Pacific
? Latin America
? Brazil
? Mexico
? Argentina
? Rest-of-Latin America
? Middle East and Africa
? Saudi Arabia
? Israel
? U.A.E
? Rest-of-Middle East and Africa

Read the full report: https://www.reportlinker.com/p05807624/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: